Alpha Tau CFO Raphi Levy's Stock Transactions - July 2026

This Form 4 filing reports stock transactions by Alpha Tau Medical Ltd. CFO Raphi Levy on July 6, 2026. Levy acquired 2,270 ordinary shares at $2.98 per share through a "M" transaction (likely exercise of options or conversion), bringing his direct holdings to 92,450 shares. On the same day, he sold 2,270 shares at $14.0011 per share, reducing his direct holdings to 90,180 shares. The simultaneous acquisition and disposal of the same number of shares suggests Levy exercised options and immediately sold the shares, potentially for tax purposes or portfolio rebalancing. The significant price difference between acquisition ($2.98) and sale ($14.0011) indicates substantial unrealized gains on the exercised options. As Chief Financial Officer, these transactions represent routine executive stock activity rather than a major corporate development.